Searched for
PHARMAC
No April Fool's joke: New Zealand hikes benefits, minimum wage and healthcare funding from April 1New Zealand will implement changes from April 1, 2025, affecting benefits, minimum wage, power prices, student loan repayments, and Pharmac...- New Zealand minimum wage to rise from April 1; check out other changesNew Zealand will see several financial changes from April 1. Benefits, Super, and Veterans Pensions will increase. The minimum wage will ri...
- Hold Torrent Pharma, target price Rs 3,320: JM FinancialJM Financial recommends holding Torrent Pharmaceuticals with a target price of Rs 3,320, up from its current Rs 3,044.3. The company, a maj...
- Cholesterol-lowering pill sparks scare in Japan after 2 deaths, over 100 hospitalisationsAccording to a report by news agency Kyodo, there have been two fatalities and over 100 hospitalizations suspected to be linked to the cons...
- Buy Torrent Pharma, target price Rs 2362: BNP ParibasTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 79292.69 Crore) operating in...
- Buy Torrent Pharmaceuticals, target price Rs 2250: Prabhudas LilladherTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 63896.81 Crore) operating in...
- Large pharma companies increasingly buying land in HyderabadThe Indian pharma industry has shown a double-digit growth of around 15% in 2021, led by the growth of Covid-19 products in the last one ye...
- Why did PM Modi's mega announcements fail to move infra stocks? Sandip Sabharwal explains“Overall, as a basket, there are opportunities in infrastructure, as as there are companies which should do very well.”
- Ahead of Market: 12 things that will decide stock action on Tuesday"Level of 14,200 is likely to act as important support zone from a near-term perspective, while sustenance above 14,500 is essential to gai...
- Mirae Asset Tax Saver mutual fund review: Has built impressive record in 5 yearsThis tax saving fund has recently completed five years of operations. It adopts the same investing ethos of its larger siblings—Mirae Asset...
- Drug sector needs boost to reduce dependency on China: IDMAIDMA said the government should take necessary steps to give a boost to the domestic sector in order to reduce imports of API bulk drugs fr...
- Two drugs manufactured by Wockhardt recalled in the USAccording to information on the US Food and Drug Administration (USFDA) website, 166 bottles of Captopril tablets of 50 mg strength are bei...
- Sensex on strong footing; top twelve stocks in focusThe Sensex rallied over 150 points in intraday trade on Wednesday led by gains in Tata Consultancy Services, ONGC, HDFC and ICICI Bank.
- Twelve stocks in focus in Wednesday morning tradeIndian markets are likely to trade in a range. Here is a list of twelve stocks which are likely to be in focus in trade today.
- Granules India shareholders approve Auctus acquisitionGranules India, a city-based pharmaceutical manufacturer, said its shareholders have approved proposed acquisition of Auctus Pharma.
- Granules India agrees to acquire Auctus PharmaThe acquisition process is expected to be completed in the next 3 to 6 months, a release from Hyderabad-based Granules India said.
- Gujarat eager to create pharma machinery clusterTo bring vibrancy in the Gujarat’s pharma machinery sector; the government is ready to provide impetus by developing specialized engineerin...
- Govt approves 8 FDI proposals worth Rs 883 crThe government has approved 8 foreign investment proposals worth Rs 883.16 crore, with L&T Finance accounting for the major inflow.
- Pharmac to fully fund Dr Reddy's brand of QuetiapinePharmac, a New Zealand Government drug funder, will fully fund a brand of Quetiapine drug made by Indian firm Dr Reddy's Laboratories.
- Is poor growth forcing analytics firms to cash out?On 9 March, Nasdaq-listed BPO company WNS signed a letter of intent to acquire Marketics Technologies, an offshore analytics service firm f...
Load More
